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ABSTRACT Lower respiratory tract illness (LRTI) is a leading cause of mortality and morbidity in
children. Sensitive and noninvasive infant lung function techniques are needed to measure risk for and
impact of LRTI on lung health. The objective of this study was to investigate whether lung function
derived from the intra-breath forced oscillation technique (FOT) was able to identify healthy infants at risk
of LRTI in the first year of life.
Lung function was measured with the novel intra-breath FOT, in 6-week-old infants in a South African
birth cohort (Drakenstein Child Health Study). LRTI during the first year was confirmed by study staff.
The association between baseline lung function and LRTI was assessed with logistic regression and odds
ratios determined using optimal cut-off values.
Of the 627 healthy infants with successful lung function testing, 161 (24%) had 238 LRTI episodes
subsequently during the first year. Volume dependence of respiratory resistance (ΔR) and reactance (ΔX )
was associated with LRTI. The predictive value was stronger if LRTI was recurrent (n=50 (31%): OR 2.5,
ΔX ), required hospitalisation (n=38 (16%): OR 5.4, ΔR) or was associated with wheeze (n=87 (37%):
OR 3.9, ΔX ).
Intra-breath FOT can identify healthy infants at risk of developing LRTI, wheezing or severe illness in
the first year of life.
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Introduction
Low lung function and lower respiratory tract illness (LRTI) in early life are both associated with increased
risk of respiratory disease in later life [1–3]. LRTI remains a leading cause of morbidity and mortality in
childhood globally [4–6], particularly in low- and middle-income countries [5, 6], potentially contributing
to the burden of later chronic respiratory disease [7]. The association of reduced lung function soon
after birth and subsequent risk of wheezing in childhood has been shown in a number of cohort studies
[1, 2, 8]. Whether baseline lung function increases risk for severe LRTI and LRTI not associated with
wheeze is not as clear [9]. Using standard lung function techniques we have previously published that
LRTIs in infancy reduce lung function in early childhood in an African birth cohort, an effect
independent of baseline lung function [10], suggesting that both baseline lung function and LRTI are
important in determining later respiratory lung function and health. Being able to accurately measure lung
function in unsedated infants is possible [11]. Ideally, the measure should be sensitive enough to pick up
small changes in lung function and be able to comprehensively characterise the mechanics of the
respiratory system. The forced oscillation technique (FOT) has been successfully used in unsedated infants
and is able to detect the impact of antenatal exposures on early-life lung function [12]. The standard FOT
calculates the average respiratory system resistance (R) or reactance (X ) during a period of quiet tidal
breathing. This method is not able to detect the changes in R and X that occur within the breathing cycle
and which may be sensitive measures of respiratory function alterations. This intra-breath analysis of
respiratory mechanics is a novel method that has been shown to detect airway obstruction [13] and
mechanical inhomogeneity [13, 14] in both children and adults, but it has not been used in infants.
Therefore, we aimed to investigate whether lung function derived from the intra-breath FOT performed
shortly after birth was able to identify healthy infants at risk of LRTI in the first year of life.
Methods
The Drakenstein Child Health Study is a prospective birth cohort conducted in a low socioeconomic
population in South Africa, with a high incidence of LRTI [15]. Mothers were enrolled antenatally and
infants were followed up at scheduled study visits. Strong surveillance systems for LRTI were used [16, 17]
and all episodes of LRTI were assessed by trained study staff. Wheezing was diagnosed on auscultation.
LRTI was defined by the World Health Organization clinical case definitions: an episode of LRTI (cough
or difficulty breathing and increased respiratory rate or lower chest wall in-drawing in a child aged
>2 months) or severe LRTI (child aged <2 months with increased respiratory rate or lower chest wall
in-drawing, or any general danger sign in a child of any age) [18].
Antenatal maternal smoking status was determined based on urine cotinine levels [19]. Maternal stress
and alcohol intake during pregnancy were assessed at 28–32 weeks of gestation [20].
The study was approved by the Faculty of Health Sciences, Human Research Ethics Committee, University
of Cape Town (401/2009) and the Western Cape Provincial Health Research Committee (Western Cape,
South Africa). Mothers gave informed, written consent in their first language for participation.
Lung function testing
Lung function was performed at the 6-week study visit in unsedated infants during quiet sleep. Respiratory
impedance (Zrs) was measured with a custom-made wave-tube FOT device [21]. Two different FOT tests
were performed. First, the conventional measurement of Zrs spectra using a pseudo-random signal
between 8 and 48 Hz was used. From at least three reproducible 30-s Zrs recordings, mean values of
respiratory resistance (Rrs) and compliance (Crs) were obtained with model fitting [12, 21]. Second, a
single 16-Hz tracking signal was used in a 60-s measurement to follow the intra-breath changes in Zrs.
Respiratory resistance (R) and reactance (X ) at 16 Hz were determined as functions of time, flow (V′) and
volume (V ), as published previously [13, 14]. The intra-breath indices derived from the steady-state
segments of the 16-Hz recordings illustrated in figure 1 are summarised and defined in table 1.
Statistical analysis
Multivariate logistic regression was used to model the predictive ability of lung function variables
measured at 6 weeks on the subsequent development of LRTI episode(s) within the first year of life.
Antenatal confounding variables defined earlier for the same population were assessed [11]. The
determinants included in the final model were: sex, length-for-age z-score, ethnicity, maternal smoking
during pregnancy, maternal HIV status and gestational age [11]. Pairwise interactions were also explored.
Determinants of the intra-breath FOT variables were established (supplementary table S1).
Data from children who had LRTI episode(s) prior to the lung function test or who were lost to follow-up
were excluded from the analysis. Logistic regression was performed using four outcomes separately: 1) any
LRTI episode, 2) recurrent LRTI, 3) hospitalised LRTI episode and 4) LRTI with wheeze during the first
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year of life. Number of LRTI episodes (recurrent LRTI) was modelled using Poisson regression. Odds
ratios, incidence rate ratios, corresponding 95% confidence intervals and p-values are presented.
Lung function variables shown to be associated with LRTI in the logistic regression were further
investigated for predictive ability. Receiver operating characteristic analysis was used to define the optimal
TABLE 1 Definitions of intra-breath impedance variables derived from the 16-Hz measurements
Variable Definition Units
Re Respiratory resistance calculated for the expiratory phase hPa·s·L−1
Ri Respiratory resistance calculated for the inspiratory phase hPa·s·L−1
Rei Respiratory resistance at the end of inspiration (zero-flow) hPa·s·L−1
Ree Respiratory resistance at the end of expiration (zero-flow) hPa·s·L−1
Xe Respiratory reactance calculated for the expiratory phase hPa·s·L−1
Xi Respiratory reactance calculated for the inspiratory phase hPa·s·L−1
Xei Respiratory reactance at the end of inspiration (zero-flow) hPa·s·L−1
Xee Respiratory reactance at the end of expiration (zero-flow) hPa·s·L−1
ΔR Volume dependence of respiratory resistance (ΔR=changes in resistance between
the beginning and end of inspiration)
hPa·s·L−1
ΔX Volume dependence of respiratory reactance (ΔX=changes in reactance between the
beginning and end of inspiration)
hPa·s·L−1
AXV Area within the reactance versus volume loops hPa·s−1
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FIGURE 1 Illustration of intra-breath changes derived from the steady-state segments of the 16-Hz recordings
of a, b) resistance (R16) and c, d) reactance (X16) in a, c) an infant who did not develop lower respiratory tract
illness (LRTI) and b, d) an infant who did develop LRTI. Arrows indicate the inspiratory limbs. The differences
between end-expiratory and end-inspiratory values of R (ΔR) and X (ΔX ) are also shown. Note the enhanced
ΔR and the opposite change in ΔX in the infant who did develop LRTI (b and d); also note the large area within
the reactance versus volume loops (AXV) indicating expiratory flow limitation in this subject (d).
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cut-off values (supplementary table S2). Using the established cut-off values, odds ratios and 95%
confidence intervals were presented.
Data are reported as median (interquartile range). A p-value <0.05 was considered as statistically
significant. Statistical analysis was performed using Stata version 14 (StataCorp, College Station, TX, USA).
Results
Of the 912 infants who attended the 6-week visit, FOT testing was successful in 719 (78%) (figure 2). Data
from 54 infants who had any LRTI episode prior to the lung function test and 38 infants who were lost to
follow-up before 1 year of follow-up completed were excluded, providing 627 infants (315 male (50.2%))
with lung function and LRTI information for this analysis. Of these, 161 (24.4%) children had a total of
238 episodes of LRTI during the first year of life, with an LRTI incidence of 0.45 (95% CI 0.4–0.5) events
per child-year for the first year of life. From the 238 LRTI episodes, 19 (8%) were severe with a case
fatality ratio of 0.4% (one death), 38 (16.0%) required hospitalisation and 87 (36.6%) were associated with
wheeze. 50 (33%) children had more than one episode of LRTI.
All infants were healthy and symptom-free at the time of lung function testing. There was no difference in
gestational age, weight or length at birth between the infants who developed LRTI (n=161) compared with
those who did not (n=466); however, males were over-represented in the LRTI group (table 2). There was
no significant difference in the prevalence of antenatal exposures that may affect lung function at 6 weeks
of age, such as maternal smoking or maternal HIV status (table 2). As a result of the successful prevention
of mother-to-child transmission programme there was only one HIV-infected infant in this cohort.
Antenatal determinants of the intra-breath FOT measures were similar to previous findings for the
standard infant lung function measures in this cohort [11], being associated with sex, infant size and
maternal HIV status (supplementary table S1). The volume dependence of R (ΔR) and X (ΔX ) as well as
Xe was associated with maternal HIV status but not with maternal smoking or alcohol intake during
pregnancy. The unadjusted differences in lung function outcomes between those infants who did and did
not experience LRTI in the first year of life are summarised in table 3. In the univariate analysis, ΔR, ΔX,
FIGURE 2 Description of cohort
tested and included in analysis.
FOT: forced oscillation technique;
LRTI: lower respiratory tract illness.
Infants recruited
(n=1147)
Excluded for LRTI prior to the lung
  function test (n=54)
Infants who did not have full year of
  follow-up (n=38)
Could not be contacted or did not
  attend the visit (n=156)
Away during the testing period
  (n=62)
Withdrawn (n=34)
Equipment not available (n=30)
Equipment or user error (n=16)
Insufficient sleep, poor test quality
  (n=147)
6-week visit completed
(n=912)
Acceptable FOT
(n=719)
Infants included in the 
final analysis
(n=627)
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Xe, Ree, Xee and area within the reactance versus volume loops (AXV) were significantly different between
infants who did and did not develop LRTI.
The reproducibility of the intra-breath impedance measures was assessed by the intra-individual
coefficients of variation (CoV=SD/mean), where the corresponding mean values of impedance magnitude
TABLE 2 Description of anthropometry and antenatal exposures measured at 6 weeks of age in
infants who did not have lower respiratory tract illness (LRTI) and infants who did have LRTI
during the first year of life
No LRTI LRTI p-value
Subjects 466 161
Anthropometry
Gestational age weeks 39 (38–40) 39 (37–40) 0.633
Male 217 (46.6) 98 (60.9) 0.002*
Black African ethnicity 243 (52.2) 83 (51.6) 0.890
Length-for-age z-score −0.73 (−1.6–0.11) −0.88 (−1.9–−0.04) 0.052
Weight-for-age z-score −0.23 (−0.94–0.43) −0.39 (−1.15–0.41) 0.155
BMI-for-age z-score 0.17 (−0.56–1.02) 0.21 (−0.62–0.97) 0.944
Antenatal exposures
Maternal antenatal smoking 336 (72.1) 128 (79.5) 0.235
Active 134 (30.3) 64 (41.6) 0.089
Passive 202 (45.7) 64 (41.6) 0.629
No exposure 106 (24.0) 26 (16.9) 0.361
No data 24 (5.2) 7 (4.3) 0.982
Maternal HIV infection 96 (19.0) 36 (22.2) 0.682
Maternal alcohol intake 46 (10.2) 19 (13.5) 0.702
LRTI episodes
Number of episodes 238
>1 LRTI episodes (number of infants) 50/161
Severe LRTI 19/238
Infants hospitalised for LRTI 38/238
LRTI associated with wheeze 87/238
Data are presented as n, median (interquartile range), n (%) or n/N, unless otherwise stated. BMI: body
mass index. *: p<0.05.
TABLE 3 Lung function measured at 6 weeks of age in infants who did not have lower
respiratory tract illness (LRTI) and infants who did have LRTI during the first year of life
Lung function No LRTI LRTI p-value#
Subjects 466 161
Respiratory rate breaths·min−1 46.8 (40.2–54.0) 49.1 (42.2–57.6) 0.027*
Rrs hPa·s·L−1 44.3 (37.3–54.0) 48.3 (37.5–57.0) 0.156
Crs mL·hPa−1 0.99 (0.75–1.28) 0.88 (0.68–1.21) 0.075
Re hPa·s·L−1 51.9 (42.7–63.9) 53.7 (43.5–66.8) 0.485
Ri hPa·s·L−1 46.8 (37.2–60.6) 48.0 (38.3–60.3) 0.702
Rei hPa·s·L−1 37.4 (29.9–47.3) 38.3 (31.4–50.2) 0.096
Ree hPa·s·L−1 42.5 (36.2–50.8) 43.9 (37.5–53.8) 0.009*
Xe hPa·s·L−1 −8.85 (−15.04–−4.97) −12.59 (−18.98–−6.92) <0.001*
Xi hPa·s·L−1 −5.12 (−8.89–−1.03) −5.15 (−9.97–−1.90) 0.405
Xei hPa·s·L−1 −4.90 (−7.58–−2.24) −5.44 (−8.60–−2.73) 0.191
Xee hPa·s·L−1 −5.69 (−9.83–−2.24) −8.88 (−14.06–−3.98) <0.001*
ΔR hPa·s·L−1 4.43 (0.65–8.13) 5.61 (1.61–11.21) 0.007*
ΔX hPa·s·L−1 −1.02 (−4.69–1.43) −2.96 (−7.52–0.53) <0.001*
AXV hPa·s 0.18 (−0.03–0.49) 0.23 (0.03–0.69) 0.011*
Results presented as n or median (interquartile range), unless otherwise stated. Rrs: respiratory resistance;
Crs: respiratory compliance; Re: expiratory resistance; Ri: inspiratory resistance; Rei: respiratory resistance
at the end of inspiration; Ree: respiratory resistance at the end of expiration; Xe: expiratory reactance;
Xi: inspiratory reactance; Xei: respiratory reactance at the end of inspiration; Xee: respiratory reactance at the
end of expiration; ΔR: volume dependence of resistance; ΔX: volume dependence of reactance; AXV: area
within the reactance versus volume loops. #: p-value of the univariate analysis. *: p<0.05.
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were considered to avoid the division by the often near-zero values of X. The results of this comparison
(supplementary table S3) indicate that the CoV of the zero-flow readings of R and X are ∼2 times higher
and of their respective differences (ΔR and ΔX ) are 3–4 times higher than the CoV of Rmean and Xmean.
The results of the logistic regression analysis of lung function variables and LRTI in the first year of life
are summarised in table 4. When values were adjusted for sex, length-for-age, ethnicity, maternal smoking,
maternal HIV status and gestational age, Xe, ΔR, ΔX and AXV were significantly and independently
associated with the development of any LRTI episode (table 4). The associations of Xe, ΔR, ΔX and AXV
with LRTI were stronger in infants who were hospitalised for LRTI, who had more than one episode of
LRTI or who had LRTI with wheeze, and included association with Ree and Xee (table 4).
The cut-off values of the relevant lung function measures and the odds ratios for predicting LRTI in the
first year of life are given in table 5. ΔX and ΔR exhibited the strongest predictive values for LRTI during
the first year of life: infants with ΔX below −2.47 hPa·s·L−1 or ΔR above 11.06 hPa·s·L−1 had 2.3 and 2.6
times greater odds of having LRTI, respectively. This effect was independent of the time between the lung
function measurement and the first LRTI episode (r=0.05; p=0.594). The odds ratios were increased if
infants required hospitalisation (ΔX: OR 3.7; ΔR: OR 5.4) or episodes were recurrent (ΔX: OR 2.5; ΔR: OR
2.4). The intra-breath FOT values Xe, ΔX, ΔR and AXV were all predictive of wheezing LRTI (table 5).
Discussion
The novel intra-breath FOT measures were strongly associated with subsequent clinical expression of LRTI
in this South African birth cohort. The association of altered lung function and LRTI risk was even
stronger for recurrent LRTI, for severe LRTI as reflected by hospitalisation and for LRTI with wheeze.
These associations were independent of gestational age, sex, body length, ethnicity or antenatal exposures.
This is the first study to use the intra-breath analysis of respiratory mechanics in an infant cohort,
establishing new outcome measures based on end-expiratory and end-inspiratory impedance data with
acceptable reproducibility. In pre-school-age children with acute and recurrent wheeze, an increased
volume dependence of R (ΔR) was identified as a measure of airway obstruction [13], and ΔR was
increased in adults with COPD [14]. In the present study, ΔR was elevated in infants who later developed
LRTI, which suggests the presence of airway obstruction in apparently healthy infants who had a higher
risk for LRTI. This is also supported by the fact that measures that have been shown to be related to
airflow limitation (e.g. AXV and Xe) were also abnormal in infants with subsequent LRTI [14, 22]. The
change in X during inspiration (ΔX ) has been found to be altered in children with asthma [13] and adults
TABLE 4 Logistic regression analysis of the lung function variables associated with lower respiratory tract illness (LRTI) during
the first year of life
Any LRTI# Recurrent LRTI¶ Hospitalised LRTI+ Wheezy LRTI§
Coefficient
(95% CI)
p-value Coefficient
(95% CI)
p-value Coefficient
(95% CI)
p-value Coefficient
(95% CI)
p-value
Respiratory rate 1.01 (1.00–1.03) 0.100 1.01 (1.00–1.02) 0.163 1.00 (0.97–1.03) 0.962 1.00 (0.97–1.02) 0.719
Rrs 1.01 (0.99–1.02) 0.431 1.01 (1.00–1.02) 0.040* 1.01 (0.99–1.04) 0.328 1.02 (1.00–1.03) 0.039*
Crs 1.28 (0.33–4.94) 0.724 1.09 (0.61–1.94) 0.771 1.08 (0.23–5.01) 0.920 1.09 (0.39–3.06) 0.870
Re 1.00 (0.99–1.01) 0.562 1.01 (1.00–1.01) 0.089 1.01 (0.99–1.03) 0.360 1.00 (0.99–1.02) 0.495
Ri 1.00 (0.99–1.01) 0.917 1.00 (1.00–1.01) 0.317 1.00 (0.99–1.02) 0.590 1.00 (0.99–1.02) 0.968
Rei 0.99 (0.97–1.02) 0.756 1.01 (1.00–1.01) 0.206 1.00 (0.98–1.02) 0.931 1.00 (0.99–1.02) 0.897
Ree 0.99 (0.96–1.01) 0.357 1.02 (1.01–1.03) <0.001* 1.03 (1.01–1.06) 0.004* 1.02 (1.00–1.04) 0.028*
Xe 0.98 (0.96–0.99) 0.004* 0.98 (0.97–0.99) <0.001* 0.96 (0.94–0.98) 0.001* 0.97 (0.95–0.99) <0.001*
Xi 1.01 (0.99–1.03) 0.381 1.00 (0.98–1.01) 0.500 1.01 (0.97–1.04) 0.713 1.01 (0.98–1.03) 0.679
Xei 1.00 (0.95–1.06) 0.865 0.99 (0.97–1.01) 0.175 0.99 (0.94–1.04) 0.663 1.00 (0.96–1.04) 0.983
Xee 1.00 (0.97–1.03) 0.992 0.97 (0.96–0.98) <0.001* 0.95 (0.92–0.98) <0.001* 0.95 (0.93–0.97) <0.001*
ΔR 1.03 (1.01–1.05) 0.013* 1.02 (1.01–1.04) 0.002* 1.10 (1.05–1.15) <0.001* 1.04 (1.02–1.07) 0.002*
ΔX 0.96 (0.93–0.98) <0.001* 0.96 (0.95–0.97) <0.001* 0.93 (0.89–0.96) <0.001* 0.94 (0.91–0.96) <0.001*
AXV 1.41 (1.06–1.87) 0.020* 1.31 (1.09–1.57) 0.004* 1.72 (1.09–2.71) 0.020* 1.63 (1.17–2.26) 0.004*
All groups referenced to infants that had no LRTI. Rrs: respiratory system resistance; Crs: respiratory system compliance; Re: expiratory
resistance; Xe: expiratory reactance; Ri: inspiratory resistance; Rei: respiratory resistance at the end of inspiration; Ree: respiratory resistance at
the end of expiration; Xe: expiratory reactance; Xi: inspiratory reactance; Xei: respiratory reactance at the end of inspiration; Xee: respiratory
reactance at the end of expiration; ΔR: volume dependence of resistance; ΔX: volume dependence of reactance; AXV: area within the reactance
versus volume loops. Antenatal confounders included in the analysis: sex, length-for-age z-score, maternal smoking during pregnancy,
ethnicity, maternal HIV status and gestational age. #: n=161; ¶: n=50; +: n=38; §: n=87. *: p<0.05.
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with COPD [14] compared with healthy controls, and this was attributed to the presence of mechanical
inhomogeneity improving progressively during inspiration [13, 14]. It is possible that the same
mechanisms govern the changes in inspiratory X in the symptom-free infants in the present study and the
more negative ΔX during inspiration represents increased inhomogeneity of the peripheral airways.
Consequently, the abnormal ΔX and ΔR values together most likely reflect an inhomogeneous peripheral
airway obstruction at functional residual capacity, which may be a risk factor in the development of LRTI
in the following months; whether this is a result of structural alteration which increases respiratory disease
susceptibility or another underlying subclinical disease process requires further investigation.
The association with early lung function and subsequent wheezing is consistent with that previously
reported [2, 3, 23]. In smaller cohorts investigating association with early-life wheezing, maximal flow at
functional residual capacity measured in sedated newborns was lower in those infants who subsequently
had bronchiolitis and/or recurrent wheeze in the first 2 years of life [3, 23]. Similarly, in the present study,
infants with low lung function reflecting airflow limitation had 3.9 times greater odds of developing
wheezing that is associated with LRTI. Additionally, a relationship between low lung function and severity
and frequency of LRTI was established. ΔR was the strongest predictor of hospitalisation: infants who had
ΔR above the cut-off had 5.4 times higher risk developing severe LRTI requiring hospitalisation. The
conventional FOT measures (e.g. Rmean and Xmean at 16 Hz) or the mechanical parameters Rrs and Crs did
not exhibit any predicting power.
The present study represents one of the largest infant cohorts and the first in a low- to middle-income
setting to assess the interaction between lung function shortly after birth and development of LRTI in
infancy. Although previous studies have reported the association of low lung function and respiratory
disease risk in infants, they have been smaller with lower incidence of LRTI [2]. An inherent limitation of
the current study may be that cut-off values for lung function measures are valid for the present cohort
and other populations may require new reference values to be established in their own settings. Ideally,
these should be tested on an independent cohort to see how widely applicable these cut-off values are,
particularly as this cohort had a high burden of respiratory disease and a high exposure to risk factors
associated with respiratory illness such as maternal smoking and maternal HIV infection. A further
limitation is that not all LRTI episodes may have been ascertained. However, given the excellent cohort
retention, careful and close follow-up and the strong, reliable surveillance systems established for LRTI
[17], and the high incidence found, this does not appear to be of concern.
The present study demonstrates that the intra-breath measures of FOT (ΔX, ΔR, Xe and AXV) are able to
detect changes in lung function that are associated with an increasing risk of LRTI in infants living in a
high respiratory disease burden setting. The lung function changes suggest that subclinical airway flow
limitation and mechanical inhomogeneity may contribute to this vulnerability. This study has hence
identified the intra-breath impedance measures as useful outcomes for lung health in infants that can be
obtained noninvasively, quickly and without sedation, making this technique a potentially useful tool in
longitudinal studies. Follow-up of this cohort will provide insight into the benefit of intra-breath measures
of FOT for longitudinal lung function assessment and the long-term impact of LRTI on lung function.
Conclusions
Impaired lung function as reflected by intra-breath impedance measurement shortly after birth increases
risk of LRTI, wheezing and severe LRTI in infancy. This new technique provides a safe and useful
assessment of lung function in unsedated infants that can be used longitudinally.
TABLE 5 Odds ratios (OR) established for the optimal cut-off values the intra-breath impedance measures for the prediction of
lower respiratory tract illness (LRTI) in the first year of life
Optimal
cut-off
Any LRTI# Recurrent LRTI¶ Hospitalised LRTI+ Wheezy LRTI§
OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value
Xe hPa·s·L−1 −13.53 1.99 (1.38–2.88) <0.001* 2.05 (1.59–2.65) <0.001* 2.97 (1.52–5.80) 0.001* 2.87 (1.81–4.55) <0.001*
ΔX hPa·s·L−1 −2.47 2.26 (1.57–3.25) <0.001* 2.46 (1.89–3.21) <0.001* 3.67 (1.81–7.46) <0.001* 3.86 (2.37–6.31) <0.001*
ΔR hPa·s·L−1 11.06 2.64 (1.68–4.14) <0.001* 2.42 (1.84–3.18) <0.001* 5.43 (2.69–10.97) <0.001* 3.02 (1.80–5.08) <0.001*
AXV hPa·s 0.10 1.75 (1.19–2.57) 0.005* 1.51 (1.14–1.99) 0.004* 2.01 (0.97–4.24) 0.065 1.90 (1.14–3.15) 0.013*
All groups referenced to infants that had no LRTI. Xe: expiratory reactance; ΔR: volume dependence of resistance; ΔX: volume dependence of
reactance; AXV: area within the reactance versus volume loops. Lung function measures were selected based on the logistic regression (see
table 4). #: n=161; ¶: n=50; +: n=38; §: n=87. *: p<0.05.
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